Shareholder plans sale of 2,064 common shares

A shareholder has filed a notice of intent to sell common stock under Rule 144.

Rhea-AI Filing Summary

A shareholder has filed a notice of intent to sell common stock under Rule 144. The filing covers the planned sale of 2,064 common shares through Fidelity Brokerage Services LLC on or about 01/22/2026, to be traded on NASDAQ at an aggregate market value of $44,923.79.

The 2,064 shares were acquired on 01/21/2026 via restricted stock vesting from the issuer as compensation. The notice also lists prior sales by James G. Chopas over the past three months, including 873 common shares sold on 01/13/2026 for $19,369.43 and 726 common shares sold on 01/20/2026 for $14,369.65.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares are planned to be sold under this APLS Rule 144 notice?

The notice covers the proposed sale of 2,064 common shares through Fidelity Brokerage Services LLC, to be traded on NASDAQ on or about 01/22/2026.

How were the 2,064 APLS shares to be sold under Rule 144 acquired?

The 2,064 common shares were acquired on 01/21/2026 via restricted stock vesting from the issuer as compensation.

What recent APLS share sales by James G. Chopas are disclosed?

The filing lists two recent sales by James G. Chopas: 873 common shares sold on 01/13/2026 for $19,369.43 and 726 common shares sold on 01/20/2026 for $14,369.65.

What is the approximate market value of the APLS shares to be sold?

The 2,064 common shares covered by the planned Rule 144 sale have an aggregate market value of $44,923.79 based on the information in the notice.

Which broker is handling the planned Rule 144 sale for the APLS shares?

The notice identifies Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917, as the broker for the planned sale of 2,064 common shares.

How many APLS shares are shown as outstanding in the Rule 144 notice?

The securities information section lists 126,525,218 common shares outstanding, which is presented as a baseline figure for the issuer’s common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/22/2026 - 04:24 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001836430
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Apellis Pharmaceuticals, Inc.
SEC File Number	001-38276
Address of Issuer	100 FIFTH AVENUE WALTHAM MASSACHUSETTS 02451
Phone	617-977-5700
Name of Person for Whose Account the Securities are To Be Sold	Chopas James George
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2064	44923.79	126525218	01/22/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/21/2026	Restricted Stock Vesting	Issuer			2064	01/21/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James G. Chopas 100 Fifth Avenue Waltham MA 02451	Common	01/13/2026	873	19369.43
James G. Chopas 100 Fifth Avenue Waltham MA 02451	Common	01/20/2026	726	14369.65

144: Remarks and Signature

Remarks
Date of Notice	01/22/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Adam Gehring, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for James G. Chopas
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)